IRIS
LAIETA, TOSCA STEFANIA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 60
EU - Europa 56
AS - Asia 17
Totale 133
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 59
IE - Irlanda 19
SE - Svezia 19
CN - Cina 15
IT - Italia 11
DE - Germania 5
FI - Finlandia 2
CA - Canada 1
IN - India 1
SG - Singapore 1
Totale 133
Salva come PNG Salva come JPEG
Città #
Chandler 30
Dublin 19
Beijing 9
Parma 7
Shanghai 4
Ashburn 3
Bremen 3
Princeton 3
Helsinki 2
Munich 2
Wilmington 2
Des Moines 1
Fairfield 1
Los Angeles 1
Milan 1
Pune 1
Redwood City 1
Rockville 1
Toronto 1
Woodbridge 1
Totale 93
Salva come PNG Salva come JPEG
Nome #
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients 52
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 52
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 32
Totale 136
Salva come PNG Salva come JPEG
Categoria #
all - tutte 632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 632
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 0 0 0 18 3 0
2020/20215 0 0 0 0 3 1 0 0 0 0 1 0
2021/202210 0 0 0 1 0 0 0 0 2 1 1 5
2022/202381 8 11 5 8 8 8 1 8 20 0 0 4
2023/202419 1 1 0 1 2 3 2 1 2 1 1 4
Totale 136